Rhodiola (Rhodiola rosea)
Author:
- Jean M. BokelmannJBJean M. Bokelmann
- 1 January 2022
- book chapter
- Published by Elsevier
- p. 535-543
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Protective Effects of Salidroside on Epirubicin-Induced Early Left Ventricular Regional Systolic Dysfunction in Patients with Breast CancerDrugs in R&D, 2012
- Rhodiola rosea for physical and mental fatigue: a systematic reviewBMC Complementary and Alternative Medicine, 2012
- Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidenceEuropean Neuropsychopharmacology, 2011
- Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cellsNeurochemistry International, 2010
- A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Standardised Extract SHR-5 of the Roots ofRhodiola roseain the Treatment of Subjects with Stress-Related FatiguePlanta Medica, 2008
- Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessmentJournal of Cosmetic Dermatology, 2008
- A Pilot Study of Rhodiola rosea (Rhodax ® ) for Generalized Anxiety Disorder (GAD)The Journal of Alternative and Complementary Medicine, 2008
- Clinical trial ofRhodiola roseaL. extract SHR-5 in the treatment of mild to moderate depressionNordic Journal of Psychiatry, 2007
- Effect of a combination of extract from several plants on Cell‐mediated and humoral immunity of patients with advanced ovarian cancerPhytotherapy Research, 2006
- Rhodiola rosea in stress induced fatigue — A double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night dutyPhytomedicine, 2000